https://www.japantimes.co.jp/news/2022/10/02/national/science-health/kowa-ivermectin-covid-19/
0
0
10/2/22 at 6:44am
Organization
The Japan Times
Author
Tomoko Otake
37 words
0
Comments
The Nagoya-based company announced the results of its clinical trial, indicating it would no longer seek the drug's approval for COVID-19 treatment.
You are the first to view
Create an account
or login to join the discussion